| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  DÔMES PHARMA Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health Type: | 21 | 9 | 14 | 129 |
 |  Oculis Oculis is a global biopharmaceutical company (Nasdaq: OCS; XICE: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal is to improve the … Type: | 3 | 1 | 2 | 45 |
 | PainNavigator Digital therapy platform for pain management providers - remote care & billing for patients with chronic pain. PainNavigator is a digital therapy platform that supports tracking patient outcomes & unlocks remote care & billing for pain management providers. PainNavigator provides an accessible and evidence-based interdisciplinary therapeutic program for patients with acute and chronic nonsurgical pain. Type: | 0 | 0 | 0 | 8 |
 | CS MEDICA Denmark-based group of companies focused on production and distribution of OTC CBD medical devices and cosmetics. CS MEDICA is a group of two fully-owned, Denmark-based subsidiaries: Galaxa Pharma A/S and CanNordic A/S, whereby CanNordic A/S is a registered Medical Device product developer and Galaxa Pharma A/S is product distributor in the Nordic Region. We see ourselves as a company in constant development, exploring the ways in which we can support patients in their battle against the disease, the pain and the sorrow it brings. Medical Device, Pharmaceuticals, Cosmetics, Regulatory Affairs, Distribution, Manufacturing, Cannabinoids, and CBD Type: | 0 | 0 | 0 | 6 |
 | Cellbox Solutions LIVE CELL SHIPMENT Cellbox Solutions is a young technology company focusing on delivering innovative and new solutions for the correct handling of living cells and biologic structures. Our product Cellbox is a self-sustaining carbon dioxide incubator supporting the appropriate storage, reproduction, transportation and analysis of biologic materials. The incubator’s temperature and gas environment can be adjusted based on the biosphere necessary for the cultivating cells stored. Biotechnology, Cell Transportation, Temperature Regulation, BioTech, Logistics, CO2 Solutions, Cell Cultures, Biological Structures, Preclinical Services, Live cell transport, portable CO2 incubator, and portable incubator Type: | 3 | 0 | 3 | 23 |
 | Virax Biolabs Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Virax Biolabs is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. medical device development, medical device distribution, Logistics, Procurement, Distribution, IOTH, Innovation, T-Cells, and immunology Type: | 0 | 0 | 0 | 24 |
 | Nuage Therapeutics We develop new selective and potent drugs for intrinsically disordered targets. Nuage Therapeutics is a spin-off from the Institute for Research in Biomedicine (IRB Barcelona) and ICREA. Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs. Type: | 5 | 2 | 2 | 22 |
 | ByoRNA The future of mRNA bioproduction. ByoRNA uses eucaryotic cells as natural biofactories to make high-quality messenger RNA (mRNAs). Our bioproduction technology will help mass produce mRNA and enhance productivity at a fraction of the current cost. By perfecting an overlooked mRNA production method, we are helping build a more sustainable planet, save cancer patients and give their grand-children a future. Type: | 6 | 3 | 4 | 7 |
 | Osta Therapeutics Developing Smart Molecules Against Superbugs Type: | 9 | 4 | 4 | 3 |
 | PharmaZell We supply the world with active pharmaceutical ingredients. PharmaZell offers a focused portfolio of small molecule APIs, together with custom development and manufacturing services for the generic and originator pharmaceutical industry. The company operates at three production sites, one in Germany and two in India. As part of the PharmaZell Group, the company employs 750 employees worldwide. Developing route of synthesis for API´s. Generic or NCE. Type: | 1 | 0 | 0 | 327 |
 | Synbio Technologies Changing the world, one sequence at a time. Synbio Technologies aims to become the most trusted provider of DNA solutions that empower scientific discoveries by providing highly-accurate and cost-effective synthetic biology services and products for researchers around the world. We have developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more. Our scientific capabilities cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology … Type: | 1 | 1 | 0 | 25 |
 | Remilk Real Dairy. No Cows. Here at Remilk, we’ve made it our mission to create real dairy without a single cow, bringing a message of hope and joy to our planet, our body... and cows! Type: | 2 | 2 | 0 | 96 |
 | Brevel Sustainable protein for the future of our planet Providing sustainable protein for a better future on this planet. Brevel's unique microalgae based protein is flavor and color neutral, has a full amino-acid profile, is highly functional and is affordable for the food industry. Thanks to our breakthrough technology, we introduce a paradigm shift to the microalgae and the plant based protein industries. Microalgae, Mixotrophy, Photobioreactor, Cultivation technology, Alternative protein, Protein, Dairy Alternatives, Egg Alternatives, and Meat Alternatives Type: | 2 | 2 | 1 | 36 |
 | Nanofaber Srl Advanced Nanotechnologies A nanobiotechnology and smart polymers company. The company is committed to products for several engineering the biomedical sectors, with an emphasis on tissue engineering, drug delivery and functionalized electrospun nanofibers. Nanofaber Srl is the exclusive distributor on the Italian soil of Bioinicia Fluidnatek Slu, leader company in Europe regarding the electrospinning equipment and services. Through its high-specialized division, Nanofaber can offer to its clients premium equipment, services and commercial/technical assistance on the electrospinning and electrospraying technology. nanofibers, SERS, oncoproteins, and nanomechanics Type: | 2 | 1 | 0 | 6 |
 | SpacePharma Bring your research idea and we will make it happen SpacePharma is a unique powerhouse offering an affordable and accessible microgravity research, together with true innovation to R&D pipelines. Our mission is to become a world leader in providing simplified and valuable, end-to-end microgravity services and solutions for research. Microgravity is a disruptive opportunity for several major sectors: pharmaceuticals, biotechnology, chemistry and materials science. It provides companies and researchers with the ability to accelerate discovery processes for new drugs and vaccines, develop new crystals and materials and accelerate the study of human genome and origin of diseases. The potential scientific, … Type: | 5 | 5 | 0 | 18 |
 | Happy Ocean Foods Tasty and nutritious plant-based seafood. Better for you & the oceans. 🌊 Happy Ocean Foods is one of the leading foodtech startups in the space of plant-based seafood, focusing on utilizing simple and functional ingredients to develop sustainable seafood alternatives. With our tasty and nutritious products we aim to restore the ecological balance in the oceans. We love nature and are passionate about a healthy lifestyle and really good food. We believe that every single one of us is able to make a difference in this world. If we change something in our behavior, this will automatically affect our immediate … Type: | 6 | 2 | 5 | 8 |
 | ARRAYS FOR CELL NANODEVICES, SL - A4CELL Lab-in-a-cell-devices Dynamic film about cell sensing SPAchip® technology is based on intracellular silicon microchips printed with multiple fluorescent probes to analyse and monitor cellular pathways at real time intracellular processes. The cell-based assays based on SPAchip® are compatible with High Content Screening platforms and imaging analysers. Suspended planar arrays, single cell analysis, cell signaling, flow cytometry, vaccines, and immunothepary Type: | 1 | 0 | 1 | 17 |
 | Aidplex MedTech Startup providing innovative solutions in orthopedics Aidplex is an orthopedics company whose patient-centric products are revolutionizing the treatment and monitoring of orthopedic patients. Starting with Scoliosis treatment, Aidplex launched ScolioSense. ScolioSense is a patent-pending medical device designed to ensure the quality of scoliosis treatment by combining portability, accuracy, and assurance of the correct fitting of the back brace. Orthopedics, HealthTech, Patient-Centric solutions, Rehabilitation, scoliosis, medical devices, and quality assurance Type: | 1 | 1 | 0 | 8 |
 | Interreg Mattisse [Automatic translation follows] 3D matrices for tissue reconstruction Application to breast reconstruction The MAT(T)ISSE project proposes to create a new bioprosthesis, a class 3 implantable medical device, which aims to help the body restore damaged areas following curative surgical procedures. This tissue restoration is done by autologous removal of fat cells (adipose tissue) reimplanted on a synthetic and resorbable lace-type textile structure. The textile structure has a role of support, helping the implanted fat cells to multiply and revascularization. It is coupled with a bioresorbable and personalized 3D shell that delimits the volume to be reconstructed. Eventually, the resorbable support … Type: | 2 | 2 | 0 | N/A |
 | Perpetua Medical AB Serial acquirer in the Healthcare sector Welcome to Perpetua Medical! We are an acquirer of profitable businesses in the healthcare sector, applying a decentralized and long-term ownership model. If you are considering selling your business, please contact us through our website. Type: | 0 | 0 | 0 | 9 |
 | Matrix Requirements Focus on medical device design, not on paperwork! We are also ISO27001 and ISO13485 certified. Matrix Requirements GmbH is a global software leader helping innovative Medical Device companies remain focused on developing safer products faster. MatrixALM & MatrixQMS reduce the regulatory burden by bridging the gap between agile & compliance to ensure quality across the entire product lifecycle. Matrix Requirements is an EN ISO 13485:2016 and ISO/IEC 27001:2013 certified company. Visit www.matrixreq.com for information. Requirements, Specifications, Traceability, Cloud, Software documentation, ISO13485, ALM, QMS, Risk Management, Controlled Documents, Medical Devices, Medical Device, Medical Device Regulation, Medical Device Software, Medical Device Requirements … Type: | 3 | 2 | 1 | 40 |
 | Axol Bioscience Ltd. Better Human Disease Models World leaders in iPSC technology supporting the next generation of advanced models for drug discovery We provide biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to support drug discovery in the neurodegenerative, neuroinflammatory, and cardiotoxicity areas. As leaders in human induced pluripotent stem cell (iPSC) products and services, we support the pursuit of more human-relevant in vitro models to develop better, safer therapies. We have over a decade of experience supplying top ten Biopharma institutions and drug discovery companies with robust, high-quality in vitro models and custom lab services. Our industry-leading iPSC … Type: | 1 | 1 | 0 | 38 |
 | Rigenerand srl Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl. Originating as a start-up from the University of Modena and Reggio Emilia developing and producing innovative products for pre-clinical and clinical applications of cell-based technologies for regenerative medicine and oncology, the cell technology company aims to fill therapeutic gaps for the many still incurable diseases by manufacturing smart treatments based on gene-modified cells with a specific focus on cancer With its team of leading cell therapy experts, Evotec (Moderna) adds a high-quality cGMP manufacturing site to the EVOcells platform increasing capacity, critical expertise, and capabilities … Type: | 1 | 1 | 0 | 5 |
 | Ncardia Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster. Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process … Type: | 1 | 1 | 0 | 60 |
 | Syngulon Original genetic technologies using bacteriocins. Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. … Type: | 5 | 2 | 2 | 10 |
 | Vivasure Medical Ltd. PerQseal® - Minimal Vascular Complications – Simply Delivered Vivasure Medical Ltd. is an ISO 13485 registered medical device company based at Europe’s leading MedTech cluster in Galway, Ireland. Founded in 2009, the company is led by an experienced management team and backed by a syndicate of international venture capital investors and state agencies. The company has developed and patented the world’s first fully absorbable, patch-based closure device specifically designed to seal large-bore arteriotomies in endovascular procedures. Please, refer to our website for further information. Medical Device, Vascular Closure, Design & Development, ISO 13485, and CE Mark Type: | 0 | 0 | 0 | 40 |
 | EV Biotech Accelerating Strain Development with smart use of models. EV Biotech is a microbial cell factory (MCF) strain development company. EV Biotech distinguishes itself by the use of state-of-the-art computational modelling. Using cutting-edge scientific developments in systems biology we create computational models of bacterial strains to predict most optimal strain modifications, growth media supplementation and scale up optimization in line with the rational design strategy. Fast-feedback loop between strain modellers and engineers increases development speed and efficiency of the MCF strain development pipeline. Preliminary models can be updated and enhanced quickly if needed, due to a close collaboration between a theoretical … Type: | 5 | 0 | 5 | 15 |
 | Eventum Orthopaedics Ltd Accessible innovation designed to improve patient outcomes Yorkshire based Med Tech company specialising in Orthopaedics. A small company planning on making a big impact ! Orthopaedics, Medical Devices, and Innovation Type: | 0 | 0 | 0 | 8 |
 | Pludi EU #plant #biotech #verticalfarm Biotechnology research and development Type: | 0 | 0 | 0 | N/A |
 | DNTOX GmbH Safe chemicals for a healthy brain development without animal experiments We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, it is supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want … Type: | 5 | 0 | 5 | 9 |
 | Sensius Balanced Treatment Sensius is focused on establishing thermotherapy as a key treatment modality for cancer patients alongside radiotherapy, surgery, chemotherapy, and immunotherapy. Sensius mission is to deliver optimized radiotherapy treatment outcomes for patients with head and neck cancer, by balancing efficacy with quality of life. medical device, hyperthermia, oncology, head and neck cancer, and thermotherapy Type: | 0 | 0 | 0 | 10 |
 | Viva In Vitro Developing novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients. Viva’s drive is saving lives by reducing in-hospital mortality from sepsis, which is the leading cause of in-hospital deaths in the world. Our mission is to develop advanced and easy-to-use devices to solve the current problem of stratification of patients in sepsis, and in other inflammatory processes; as well as contributing to the development of novel therapies using cutting-edge scientific knowledge in the area of inflammasomes. sepsis , IVD, diagnostics, medical devices, biotech, prognosis, stratification, septic shock, acute inflammation, inflammatory diseases, inflammasomes, nlrp3, biomedical, and … Type: | 1 | 1 | 1 | 8 |
 | Linari Medical [Automatic translation follows] Technologies for telerehabilitation of neurovisual hemianopsia patients. Linari Medical has patented an innovative technology for remote visual rehabilitation of brain-damaged visually impaired patients called AvDesk. The system consists of a medical device that emits special audio-visual stimuli based on the patient's disease and processes the patient's feedback in the cloud to be analyzed remotely by a specialist. AvDesk is a class I medical device and can be used in medical clinics or even at home. telemedicine, CVI, visually impaired, e-health, visual rehabilitation, visually impaired, hemianopsia, quadrantopsia, telerehabilitation, and healthcare Type: | 3 | 0 | 2 | 10 |
 | Ascend Advanced Therapies Ascend is a gene therapy development partner with a flexible platform featuring industry-leading analytics. Ascend is gene to GMP partner with deep expertise in gene therapy development and commercialization. We offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business. To set a new standard in the industry, we have invested in a world-class analytical toolkit within our flexible and scalable AAV platform of next-gen technologies, all built to find the perfect balance of yield and quality for each … Type: | 3 | 0 | 3 | 115 |
 | Nodus Oncology Developing next generation DDR targeting therapies Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response. Supported by most recent scientific advances, we are developing the next wave of cancer therapeutics in the DNA damage response (DDR) area. Founded by Cumulus Oncology and in partnership with the Lead discovery Center, Nodus Oncology is developing an innovative portfolio focused on synthetic lethality and collateral vulnerabilities in molecularly defined cancer patient populations Oncology Type: | 0 | 0 | 0 | 7 |
 | Valo Therapeutics Ltd Reinventing Cancer Immunotherapy Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea … Type: | 0 | 0 | 0 | 17 |
 |  Fada Medical Improving the delivery of insulin for people with type 1 diabetes through extended wear devices Fada Medical's mission is to optimize chronic drug therapy, making life easier for the people who need it. Starting with insulin delivery for those with type 1 diabetes, Fada Medical are developing novel diffusion technologies to prevent and negate the causes of early infusion set failure and cannula occlusion that make insulin therapy more difficult. Type: | 0 | 0 | 0 | 2 |
 | Telea Telea | An award-winning software that links Speech Therapists and their clients Telea | An award-winning software that links Speech Therapists and their clients to enable therapists to provide at-home speech therapy. Type: | 1 | 0 | 1 | 4 |
 | Recolony AG Bacteria-based cancer therapy Recolony is a Swiss biotech start-up with the goal of developing a bacteria-based oral therapy to treat and prevent cancer. Type: | 1 | 0 | 0 | 9 |
 | NRG Therapeutics Mitochondrial therapeutics for the treatment of neurodegenerative diseases Type: | 5 | 0 | 5 | 12 |
 | TILT Biotherapeutics Ltd To make T-cells kill cancer, TILT is the answer TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his … Type: | 4 | 0 | 4 | 24 |
 | Angiodroid Automated Carbon Dioxide Angiography with Angiodroid the CO2 Injector Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack … Type: | 3 | 0 | 0 | 45 |
 | Maxion Therapeutics Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins. Type: | 1 | 0 | 1 | 33 |
 | FluoSphera The only company with a suite of systemic and high-throughput in vitro drug discovery solutions FluoSphera S.A. is the only company providing a suite of high-throughput, systemic, in vitro drug discovery solutions. Its proprietary chip-free platform uses flexible 3D cell systems that mimic the complex biology of the human body to rapidly and precisely study human response to systemic drug delivery. FluoSphera offers four distinct drug discovery solutions: (1) multiplexing for target selectivity, (2) measuring systemic efficacy and toxicity, (3) systemic biomarker identification, and (4) translational species optimization. Type: | 6 | 0 | 6 | 4 |
 | Resalis Therapeutics Tackling metabolic disorders with non-coding RNAs Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders. Type: | 0 | 0 | 0 | 9 |
 | Evonetix Ltd Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio Type: | 3 | 0 | 3 | 38 |
 | Hemab Therapeutics The next generation of therapeutics for bleeding and thrombotic disorders Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious … Type: | 1 | 0 | 1 | 47 |
 | TissueLabs The platform for creating organs and tissues in the lab. The platform for creating organs and tissues in the lab. Biotechnology, Biomaterials, Bioprinting, 3D Cell Culture, Tissue Engineering, Hydrogels, Regenerative Medicine, Research, and Tissue Culture Type: | 3 | 1 | 1 | 14 |
 | Tetra Pharm Technologies We do science Tetra Pharm is a research focused biopharmaceutical company. Type: | 2 | 0 | 2 | 40 |
 | Amferia kills bacteria Amferia kills bacteria, even resistant bacteria, without harming the body Amferia AB is a Swedish company that develops and markets new medical devices with emphasis on antibacterial products. The core focus of Amferia is to develop materials that can efficiently kill bacteria when used as medical devices, for example within wound care. Amferia is a spin-off from research performed at Chalmers University of Technology. The company was founded in 2018 and the founders of Amferia are Dr. Anand Kumar Rajasekharan, Professor Martin Andersson and Dr. Saba Atefyekta. Antibacterial materials, Antibiotic resistance, Elastomers, and Injectable Materials Type: | 0 | 0 | 0 | 10 |
 | Machine Bio Machine Bio is a biotech company offering unique protein synthesis and purification solutions. Machine Bio is an early stage biotechnology company developing a novel, proprietary protein synthesis platform that can produce pure protein from a DNA template in a easy-to-use, single-step, 4 hour process. Proteins are broadly used in many industries and Machine Bio’s platform has a range of possible applications across drug discovery and development, synthetic biology research, industrial enzyme optimization, and commercial therapeutic manufacturing. Protein Synthesis, Protein Purification, Contract Protein Expression, R&D, Startup, Cell-Free Systems, and Supported Lipid Bilayer Type: | 1 | 1 | 0 | 3 |
 | ExeVir Rapid Viral control in a world that needs it Exevir Bio is a biotech company developing efficacious heavy chain-only antibodies to prevent and treat infectious diseases and make a difference in pandemic preparedness. The technology platform of ExeVir uses humanized camelid heavy chain-only antibody fragments (VHH) fused to a human IgG Fc to create new therapeutic compounds. ExeVir is building a strong pipeline of antibody therapies with an initial focus on COVID-19 and dengue. Compared to conventional monoclonal antibodies, the modular VHH building blocks provide a unique combinatory flexibility. In addition, the design of multi-specific constructs is substantially simplified. VHHs … Type: | 2 | 0 | 1 | 21 |
 | NapiFeryn BioTech We developed and patented a #technology to obtain #food grade #proteins from #rapeseed (#canola) and other oilseeds. Beneficiary of #SMEInstrument #H2020 and the proud member of #RisingFoodStars #EITFood The NapiFeryn technology makes it possible to retrieve all protein contained in rapeseed, which makes the proposal unique worldwide. biotechnology, food industry, alternative proteins, rapeseed protein, and raptein Type: | 6 | 2 | 5 | 19 |
 | DeuterOncology NV Developing deuterated BEST in CLASS MET kinase Inhibitor DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2. Drug Development, Deuterated small molecules, and MET kinase inhibitor Type: | 0 | 0 | 0 | 4 |
 | Rewind Therapeutics Rewind Therapeutics is developing first-in-class remyelinating therapies for myelin-related diseases and aims to bring them into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition and movement, among others. The causes of damage may be genetic, a result of infectious or autoimmune disease or from exposure to toxic agents or other forms of brain injury. There is no cure for demyelinating diseases. The Company was founded by KU Leuven’s Centre for Drug Design and Discovery (CD3) and … Type: | 0 | 0 | 0 | 20 |
 | NeoPhore Ltd Discovering drugs that create neoantigens NeoPhore, UK is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. Generation of cancer neoantigens in tumours can be exploited by the patients’ immune system to overcome natural defence mechanisms in cancer. The Company’s approach targets the DNA mismatch repair (MMR) pathway, which has been proven to promote neoantigen creation and subsequent immunity against numerous cancers. Using these insights, NeoPhore aims to generate next-generation immuno-oncology therapeutics to improve clinical outcomes for cancer patients. NeoPhore was spun-out of the University of Turin and PhoreMost … Type: | 1 | 0 | 1 | 16 |
 | QV Bioelectronics Delivering longer, better quality lives for brain tumour patients QV Bioelectronics is a VC-backed medical device startup developing an implantable electric field therapy treatment for aggressive brain tumours. Type: | 4 | 0 | 4 | 16 |
 | MgShell S.r.l. La sfida che ci proponiamo è quella di rivoluzionare completamente l'approccio terapeutico nel campo oftalmico. The hard clinical context related to the age-related macular degeneration or maculopathy, chronic ocular disease and first cause of blindness in developed countries, has to be solved. The number of affected patients is increasing drastically with 500'000 new cases per year and a pool of 260 million patients is estimated for 2040. Despite the noted efficacy of the drug, the intravitreal injections to which patients are subjected monthly implies a high rate of treatment dropout, followed by a very high risk of irreversible blindness condition. … Type: | 2 | 0 | 1 | 5 |
 | Neuria Digital Therapeutics Solutions for behavioral change and rehabilitation Neuria is an award-winning Swiss company developing science-based solutions to improve public health. Our team of neuroscientists, engineers and gaming professionals provides software and solutions for large-scale behavioral change interventions, neuropsychiatric remediation and to facilitate scientific research. Neuria is the first worldwide to propose evidence-based Dtx to modulate the brain reward system to restore healthy consumption behaviors and improve health. Digital therapeutics, Gamification, Health care, Public Health, and Online interventions Type: | 2 | 0 | 1 | 10 |
 | Refined Laser Systems GmbH Label-free and chemically specific imaging for life science and medical diagnostics Refined is a young biophotonics company from Münster, Germany, aiming to transform the treatment of cancer. During today's cancer treatments, surgeries must be repeated in up to one third of all cases because it remains a challenge to quickly identify cancer cells without extensive biopsy processing. With its pioneering laser technology, combined with advanced microscopy methods and artificial intelligence, Refined has stepped up to empower surgeons and pathologists to overcome this challenge. fiber laser, picosecond laser, 2-photon microscopy, and microscopy Type: | 2 | 0 | 2 | 14 |
 | Humane Genomics Platform to engineer cancer killing viruses using synthetic biology. Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21) Type: | 5 | 1 | 5 | 5 |
 | PepGen Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics Type: | 1 | 1 | 0 | 84 |
 | GC Therapeutics A Path to SuperCellsTM Therapies GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCellsTM by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients. Type: | 1 | 0 | 1 | 41 |
 | The National Center for Children and Families Donate. Volunteer. Make Change. Founded in 1915 as an orphanage in the District of Columbia, NCCF is a private, nonprofit child and family welfare agency with a commitment to serving poor, disadvantaged, abused, neglected and/or abandoned children, youth, and their families. Current program services include emergency shelters and transitional housing for homeless families, a high-intensity therapeutic group home, therapeutic and traditional foster care and adoption, independent living for youth transitioning to adulthood, teen parent services, and community-based prevention services that promote academic achievement, parental involvement, economic and vocational stability, and healthy families. Our programs have become social service models, redefining … Type: | 3 | 0 | 3 | 195 |
 | Fallbrook Engineering, Inc. 38 years of Product Development Excellence~ Engineering & Design~Medical Device & Biopharma~Protype to Product. Fallbrook Engineering is a contract product development, management, and engineering services consulting firm. We accelerate companies' introduction of new products into the market place. We are experts in the design and development of diagnostic and therapeutic systems, processes, components and products. We improve manufacturing methods. We solve manufacturing problems. We provide full regulatory support for your compliance needs. Fallbrook Engineering provides engineering design and product development for many business requirements, including rapid execution of projects that exceed the availability or expertise of your existing staff, or … Type: | 0 | 0 | 0 | 9 |
 | Nephron Pharmaceuticals Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD. Manufacturer of generic respiratory medications and Contract manufacturing blow-fill-seal medications Type: | 5 | 0 | 0 | 861 |
 | Modulim An ounce of prevention is priceless. Modulim is a pioneer in optical imaging solutions powered by spatial frequency domain imaging (SFDI) for noninvasive tissue and vascular assessment. Powered by SFDI, our Clarifi® Imaging System helps clinicians identify patients at-risk of complications due to microvascular dysfunction. The #ClarifiImagingSystem quantifies and maps five biomarkers of microvascular tissue oxygenation and perfusion. As a result, clinicians can quickly identify at-risk patients for earlier and more timely intervention so they may prevent complications such as diabetic foot ulcers and amputations. With its widespread adoption, our technology solutions have the potential to save limbs and lives, … Type: | 1 | 0 | 1 | 10 |
 | Wilson Health We're With You...Today, And Always. At Wilson Health, improving the health of the community is at the heart of our mission. Our continued growth and expansion of health services and physicians, plus strong partnerships and collaborations, are all part of Wilson Health’s purpose to offer better healthcare to our communities, so people can spend more time doing what they love with those they love. For more information or to view a full list of the services offered at Wilson Health, visit www.wilsonhealth.org. Emergency Services, Occupational Health, Orthopedic Surgery, Women's Health, Cardiology Services, Behavioral Health, Surgical Services, Home Health, Hospice, Sports … Type: | 0 | 0 | 0 | 462 |
 | IAVI Translating science into global health impact. Translating scientific discoveries into affordable, globally accessible public health solutions. IAVI is a non-profit that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. AIDS vaccine, research and development, product development partnership, HIV/AIDS, vaccine development, global health, capacity strengthening, clinical trials, and scientific research Type: | 13 | 5 | 9 | 436 |
 | Pentec Health The provider of choice for renal nutrition therapy and intrathecal pump management. Pentec Health improves healthcare by solving and simplifying complex care challenges not addressed by other providers. Our unique solutions, based on empathy, technical expertise, and collaboration, deliver exceptional results through proven delivery models that honor patients’ and providers’ time and needs and improve outcomes through trusted, long-term relationships. Type: | 1 | 0 | 0 | 424 |
 | Sarcos Robotics Sarcos Robotics is now Palladyne AI. Please follow us at https://www.linkedin.com/company/palladyneaicorp Sarcos Technology and Robotics Corporation (NASDAQ: STRC) (NASDAQ: STRCW) is a leader in advanced robotic technology designed to increase the intelligence, efficiency, capability and productivity of advanced robotic systems. Sarcos robotic artificial intelligence and machine learning software enables generalizable autonomy to address challenging, dynamic environments for industries that require a high degree of adaptability and efficiency. For more information, please visit www.sarcos.com robotics, robots, military, robot, aviation, AI/ML software, software, ai software, and ml software Type: | 8 | 2 | 6 | 182 |
 | Whitehead Institute A world-renowned non-profit research institution dedicated to improving human health through basic biomedical research Whitehead Institute for Biomedical Research is a leading, nonprofit research and educational institution that has defined the cutting edge of biomedical science, creating a legacy of research excellence and academic eminence since 1982. Wholly independent in its governance, finances and research programs, Whitehead shares a teaching affiliation with Massachusetts Institute of Technology, offering the intellectual, collegial and scientific benefits of a leading research university. Whitehead provides scientists with the resources and freedom to follow their scientific instincts, form novel collaborations and conduct high-risk research. While probing … Type: | 8 | 2 | 2 | 385 |
 | American Association for the Study of Liver Diseases (AASLD) Our mission: To advance and disseminate the science and practice of hepatology, and to promote liver health and quality The American Association for the Study of Liver Diseases (AASLD) is the nation’s premier organization of physicians, scientists, researchers, medical students, and healthcare professionals to study, prevent, and cure liver diseases. AASLD was founded in 1950 by a group of leading liver specialists to advance the field of hepatology. The mission of AASLD is to advance and disseminate the science and practice of hepatology and to promote improved liver health and quality patient care. AASLD has more than 7,000 + members … Type: | 10 | 5 | 2 | 89 |
 | Cell Press Cell Press publishes over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies. Our story began over 45 years ago with the journal Cell and a commitment to publishing exciting biology. Today, we are bringing our editorial excellence, commitment to innovation, unparalleled reach and visibility, and passion for advocacy to all areas of scientific exploration as we work to publish and share science that inspires. To learn more, visit www.cell.com/about. Publishing, Biomedical Journals, Life Science Journals, and Research Reviews Type: | 25 | 6 | 15 | 387 |
 | DIA Driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries. Professional Association, Pharmaceuticals, Medical Devices, Biotechnology, Education Provider, Government, Clinical Trials, Education, Training, eLearning, Translational Medicine, Patient Engagement, Value and Access, healthcare, regulatory affairs, Pharmaco Vigilance, personaldevelopment, careers, … Type: | 24 | 8 | 17 | 463 |
 | Mersana Therapeutics Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer. At Mersana, we have a passion for advancing therapies to make a significant impact in the lives of people living with cancer. Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers. Its pipeline … Type: | 4 | 1 | 3 | 166 |
 | THERAVECTYS Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective … Type: | 2 | 2 | 0 | 19 |
 | MANDALA International REGULATORY AFFAIRS SPECIALISTS AND REGISTRATION HOLDER MANDALA International offers consulting and operational support for healthcare-related companies seeking to develop their business in Latin America with a special focus on Brazil, Mexico and Colombia. Apart from this, we provide support for CE mark to enter European countries. MANDALA International is the world’s leader for Medical Device & Pharmaceutical Registration in Brazil (ANVISA), Mexico (COFEPRIS), Colombia (INVIMA) and Europe (CE). It is the only service provider authorized to import and distribute drugs in Brazil (Brazilian Registration Holder) and to run an ANVISA-approved laboratory to register pharmaceuticals. MANDALA specializes in the healthcare industry … Type: | 0 | 0 | 0 | 21 |
 | OMéDIT Normandie [Automatic translation follows] Observatory of Medicines, Medical Devices and Therapeutic Innovations OMéDIT Normandie is a regional structure for support, evaluation and independent scientific expertise, placed with the ARS. It is strongly committed to supporting and implementing quality, safety and medico-economic efficiency approaches related to medicines and medical devices, for patients and health professionals. Type: | 5 | 1 | 4 | 4 |
 | DTF medical NOUS AGISSONS POUR ACCOMPAGNER LA VIE Based in Saint Etienne (France) since 1951, DTF medical specializes in the design, manufacture and sale of top-quality, innovative medical devices. This family owned company, which have been managed by two founding families members for three generations, is recognized via the brands Kitett, Atomisor and Matelas DTF in France and abroad. Backed by powerful research capabilities, an enthusiastic and committed personnel, DTF medical serves the needs of patients and care professional alike. Its mission is to serve and assist them at every life stage. Breast feeding, Aerosothearpy & Nebulizing, Pressure Ulcer Prevention & Treatment, … Type: | 2 | 2 | 1 | 65 |
 | STRATEGIQUAL SAS Strategiqual is a consulting company located in the center of Paris and operating in Europe, with extensive experience in Europe and the US. Its area of expertise covers pharmaceutical products, medical devices and biotechnology. Strategiqual has in-house expertise in the areas of regulatory affairs, strategic plans, gap analysis, risk analysis, audits, product compliance, quality management systems implementation. Specialties : - Systems approach for designing Quality Management Systems (pharmaceutical products, medical devices, biotechnology) - Drug device combinations (the so called "rule 13" of directive 93/42/CEE) - Innovative medical devices: quality and regulatory approaches Strategiqual is part of ProductLife Group (PLG) since … Type: | 6 | 6 | 1 | 57 |
 | AXEME Récoltez le talent, cultivez l'innovation ! Founded in 2004, Axeme is a recruitment agency specialized in the field of Life Sciences, Medical Devices, In Vitro Diagnostics and Biotechnologies. We recruit specific profiles from the development of a product or solution to the marketing phase including highly scientific and technical profiles. Research and development, quality, regulatory affairs, clinical, field specialist, business, marketing profiles to c-level positions in France and worldwide. We share our knowledge and force with startups, medium-sized and major companies in medical device to structure their organization. Christine Horvais, the founder, has set up a European network of consultants … Type: | 12 | 1 | 6 | 11 |
 | Monument Therapeutics Bringing Precision Medicine to Neuroscience Drug Development Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience … Type: | 0 | 0 | 0 | 7 |
 | CELLUGY® Creating sustainable materials to replace fossil based material/polymer through biofabrication! We are a Danish biotech startup based in Søborg, with global ambition. We created superior material from nature's most abundant building block, cellulose. biodegradable material, sustainable material, plastic replacement, environmental packaging, green technology, biotechnology, personal care, textiles, cellulose, personal care products, and cosmetics Type: | 6 | 2 | 0 | 18 |
 | Tandem Therapeutics Unlocking the matrix barrier to treat fibrotic diseases TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases. Type: | 0 | 0 | 0 | 5 |
 | Allegria Therapeutics Mastering Mast Cells Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases. For more information, please visit www.allegriatx.com Mast Cell-Targeted Therapeutics, Allergy, and Inflammatory Disease Type: | 0 | 0 | 0 | 2 |
 | Metsystem Personalized cancer patient treatment that targets metastasis. Personalized cancer patient treatment that targets metastasis. We can treat preventatively and create better patient outcome. Metsystem is developing a metastasis-targeting drug screen platform that is capable of predicting the most effective drug for each patient. With an accurate drug screen we can guide treatment and create better patient outcomes. Type: | 3 | 1 | 2 | 20 |
 | Point Pressure Developing the next big leap in spasticity treatments. Point Pressure is developing a medical device to help patients with chronic diseases or conditions experiencing spasticity through a non-invasive physical treatment. The main aim of the instrument is to treat spasticity symptoms resulting in a wider motion of the affected limbs. Type: | 2 | 1 | 0 | 7 |
 | NeuroBell Medical device company developing newborn brain monitoring solutions. Neurobell develop novel products for early detection and monitoring of neonatal seizures to facilitate better treatment and patient outcomes. Type: | 2 | 0 | 1 | 10 |
 | Double Bond Pharmaceutical International AB Double Bond Pharmaceutical is a fast growing pharmaceutical company that develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company is to provide patients and the market with more efficient and safe products especially in areas where these needs are unmet. The human population is growing and also the life-span is increasing. Many children born today can be expected to live until they are about 100 years old. By these reasons it can be expected that the need for efficient therapies for treatment of different diseases will … Type: | 0 | 0 | 0 | 14 |
 | Predictiv Care 🧬 DNA-based Digital Twin to help predict and prevent diseases and adverse reaction to drugs Personal genomics solution for predictive medicine—Thanks to unique and groundbreaking technology, Predictiv identifies the genetic predispositions of an individual on 22,000+ diseases and simulated reactions to 750+ drugs. Now enabling more accurate preventive actions and treatments. genomics, predictive medicine, preventive medicine, heathcare, and biotechnology Type: | 18 | 3 | 14 | 12 |
 | Age Labs AS Extending human healthspan Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead. However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice. But how do we know these treatments will work in humans? We can wait and see if patients receiving … Type: | 0 | 0 | 0 | 4 |
 | Sigrid Therapeutics 100% Natural Stability For Your Blood Sugar Levels and Weight With science-backed, 100% natural solutions, we empower journeys toward balanced and healthier lives by optimizing metabolism and making well-being achievable every day. prediabetes, diabetes, blood sugar management, healthtech, obesity, innovation, medical device, biotech, and life science Type: | 2 | 1 | 2 | 18 |
 | HelloBetter Leading provider of prescription digital therapeutics (PDTx) for mental health with the strongest evidence base globally HelloBetter is a European leader in the field of digital therapeutics (DTx) for mental health and a global pioneer in digital mental health research. Founded in 2015, HelloBetter has the strongest evidence base globally, with a total of 33 randomized controlled trials published in peer-reviewed journals. In Germany, six of their therapy programmes are part of the standard of care and as such available to 70+ million people for free as prescription digital therapeutics or DiGA. In 2022, HelloBetter entered the US market with … Type: | 5 | 1 | 3 | 145 |
 | Carbiotix Pioneering onsite upcycling of plant-based side-streams Carbiotix is an award-winning biotechnology company pioneering the onsite upcycling of plant-based side-streams. Carbiotix mission is to improve the health of people by increasing the consumption of prebiotics and other active ingredients from upcycled side-streams. Carbiotix offers one core service today called NutraCycle, an on-site upcycling and fortification service allowing food & beverage, ingredient, and feed producers to turn plant-based products into healthier, more profitable, and sustainable products. Gut Health, Microbiome, Prebiotics, Upcycling, Plant-based, Food & Beverage, Ingredient, Feed, Biotechnology, Process Engineering, Product Design, Active Ingredients, and Onsite Type: | 0 | 0 | 0 | 15 |
 | Samsara Therapeutics Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development Type: | 1 | 0 | 1 | 22 |
 | SENISCA Applying world-leading molecular genetics to solve the diseases and aesthetic signs of ageing SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics). Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells. At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new … Type: | 1 | 0 | 1 | 21 |
 | Life Length Measuring life for the world Founded in 2010, Life Length stands out as a global leader in diagnostic biotechnology, specializing in telomere diagnostics. Our proprietary platform technology, TAT®, is based on the measurement of telomere variables and assays related to aging and age-related diseases. This patented technique allows quantification of telomere length at the individual cell level and is applicable to blood, cell culture and tissue samples. Recently, we have developed a biomarker for the early detection of prostate cancer with this technology. This biomarker is authorized by the AEMPS in Europe and by the CMS in the United States, … Type: | 2 | 1 | 2 | 51 |
 | Uncommon We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering. Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the … Type: | 9 | 2 | 5 | 63 |
 | Salvia BioElectronics Giving people with migraine a better life | Medical device company pioneering migraine therapy | Located in NL & AUS Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empower people with migraine to reclaim their lives. Our personalized migraine therapy is tailored to the needs of individual patients. And our ambition doesn’t stop there. With our unique bioelectronic technology, we are also exploring applications for other neurological disorders. Our unwavering commitment is driven by a deep desire to restore hope, health and … Type: | 1 | 0 | 1 | 48 |
SMB